Weight loss stomach pump is an external device that drains of stomach insides into the latrine. Calorie absorption i.e. weight gain by body can be effectively controlled by this weight loss stomach pump device. This device consists of a thin tube set in the stomach to the outside part of the stomach. This device is offers an easier way to reduce weight compared to people who routinely have organized diets, set of devices or surgeries to reduce their stomach. Patients who want to diminish their calorie consumption should be consulted by dieticians, health care consultants or by the fitness trainers. According to the clinical trial report, usually a patient observes a weight loss of around 46 pounds in their first year and 50 pounds in the succeeding year.
Market for stomach pumps is expected to increase at higher rate due to increase in patients having by-pass gastric surgery and an extra obesity issues. Moreover, weight loss stomach pump market is likely to grow at a noteworthy CAGR owing to their capacity to drop the weight of the body with least tactlessness. These pumps are frequently utilized by bulimia nervosa (an eating disorder) patients aging 22 and further. Worldwide upsurge in non-surgical treatments, an increase in obesity and bulimia patients and change in lifestyle habits will correspondingly support the weight loss stomach pump market growth. Nevertheless, side effects accompanied by surgery are firm challenges which might hamper the growth of the market.
The weight loss stomach pump market is bifurcated on the basis of disease type, end-user, and geography. By disease type, the market for weight loss stomach pump is bifurcated into bulimia, anorexia, and diabetes. Unhealthy lifestyle is impelling in growing obesity associated ailments among healthy environment. Therefore, weight loss stomach pump would play a key role in successful control over obesity. By end-users, the market for weight loss stomach pump is bifurcated into hospitals, clinics, nursing homes among others. The weight loss stomach pump suppliers offer specific programs to the end-users supporting in management of health plans by offering solutions to growing costs of complexities during treatment.
In terms of geography the weight loss stomach market is segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa (MEA). North America dominates the market for weight loss stomach pumps owing to the technological development in the region. Countries such as Canada and United states have succeeded in executing weight loss stomach pump in their healthcare structure, which in turn is expected to boost the market for weight loss stomach pumps over the forecast period. Furthermore, presence of favorable government initiatives, improved healthcare infrastructure in implementing weight loss stomach pumps in the existing healthcare organizations will boost the growth of weight loss stomach pumps market. Moreover, persistently improving reimbursement development would further drive the market growth. Europe was perceived to be the second largest market in the weight loss stomach pumps due to improved weight loss therapy in the healthcare infrastructure coupled with the execution of stomach pump, a weight loss device in the region.
The US FDA permitted novel obesity treatment devices in June 2016 such as Aspire Assist System which is appropriate for moderately overweight patients. FDA studied results from a clinical trial of 111 patients treated with AspireAssist and suitable lifestyle therapy. The players operating in the weight loss stomach pump market include Aspire Bariatrics, Inc. (AspireAssist System), snd Apollo Endosurgery, Inc. (ORBERA balloon), among other significant players worldwide.
Market by Disease Type
Market by End User
· Nursing homes
Market by Geography
· North America
o Rest of Europe
o Rest of Asia-Pacific
· Latin America
o Rest of Latin America
· Middle East and Africa (MEA)
o South Africa
o Saudi Arabia
o Rest of MEA
Introduction: Meningococcal vaccines are utilized to treat meningitis brought about by bacterium N. meningitidis. Beforehand there were no careful steps accessible to maintain a strategic distance from meningitis. Anti-infection agents alongside supplement supplements were utilized to treat this ailment after the disease was affirmed. In any case, with the approach of the meningoco
Introduction According to Acumen Research and Consulting, the global Sports Medicine market is expected to grow at noteworthy CAGR around 7% throughout the forecast period and reach around US$ 13 billion by 2026. Sports Medicine is a genetic disorder that causes structural abnormalities in hemoglobin molecules. Hemoglobinopathie
Introduction According to Acumen Research and Consulting, the global Real-time PCR (qPCR) & Digital PCR (dPCR) market is expected to grow at noteworthy CAGR around 8.1 % throughout the forecast period and reach around US$ 4.2 billion by 2026. In order to amplify or make more copies of the deoxyribonucleic acid (DNA) sequence
Introduction According to Acumen Research and Consulting, the global Nebulizer market is expected to grow at noteworthy CAGR around 6.2 % throughout the forecast period and reach around US$ 1.4 billion by 2026. Nebulizer is a medical device that converts the medicine into a nebula and directly into the pulmonary system. Nebuliza
Introduction According to Acumen Research and Consulting, the global Motion Preservation Devices market is expected to grow at noteworthy CAGR around 10.5 % throughout the forecast period and reach around US$ 1.5 billion by 2026. In spinal disorders, movement preservation devices are used. Motion conservation devices are used to
Introduction According to Acumen Research and Consulting, the global Hemoglobinopathy market is expected to grow at noteworthy CAGR around 10 % throughout the forecast period and reach around US$ 12 billion by 2026. Hemoglobinopathy is a genetic disorder that causes structural abnormalities in hemoglobin molecules. Hemoglobinopa